Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Crinetics Pharmaceuticals stock

Learn how to easily invest in Crinetics Pharmaceuticals stock.

Crinetics Pharmaceuticals Inc is a biotechnology business based in the US. Crinetics Pharmaceuticals shares (CRNX) are listed on the NASDAQ and all prices are listed in US Dollars. Crinetics Pharmaceuticals employs 93 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Crinetics Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CRNX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Crinetics Pharmaceuticals stock price (NASDAQ: CRNX)

Use our graph to track the performance of CRNX stocks over time.

Crinetics Pharmaceuticals shares at a glance

Information last updated 2022-01-17.
Latest market close$24.01
52-week range$13.83 - $28.95
50-day moving average $26.29
200-day moving average $21.33
Wall St. target price$43.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.79

Buy Crinetics Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Crinetics Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Crinetics Pharmaceuticals price performance over time

Historical closes compared with the close of $24.01 from 2022-01-14

1 week (2022-01-10) -3.50%
1 month (2021-12-16) 0.33%
3 months (2021-10-18) 24.08%
6 months (2021-07-16) 21.75%
1 year (2021-01-15) 68.97%
2 years (2020-01-17) 0.92%
3 years (2019-01-18) 4.39%
5 years (2017-01-14) N/A

Crinetics Pharmaceuticals financials

Gross profit TTM $-56,927,000
Return on assets TTM -30.09%
Return on equity TTM -51.73%
Profit margin 0%
Book value $5.01
Market capitalisation $1.1 billion

TTM: trailing 12 months

Crinetics Pharmaceuticals share dividends

We're not expecting Crinetics Pharmaceuticals to pay a dividend over the next 12 months.

Crinetics Pharmaceuticals share price volatility

Over the last 12 months, Crinetics Pharmaceuticals's shares have ranged in value from as little as $13.83 up to $28.95. A popular way to gauge a stock's volatility is its "beta".

CRNX.US volatility(beta: 1.34)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Crinetics Pharmaceuticals's is 1.3436. This would suggest that Crinetics Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Crinetics Pharmaceuticals overview

Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist that has completed phase II clinical trial for the treatment of acromegaly, as well as completed phase 1 clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist to treat congenital hyperinsulinism, which is in phase 1 clinical trial; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase 1 clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California. .

Frequently asked questions

What percentage of Crinetics Pharmaceuticals is owned by insiders or institutions?
Currently 3.548% of Crinetics Pharmaceuticals shares are held by insiders and 89.484% by institutions.
How many people work for Crinetics Pharmaceuticals?
Latest data suggests 93 work at Crinetics Pharmaceuticals.
When does the fiscal year end for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals's fiscal year ends in December.
Where is Crinetics Pharmaceuticals based?
Crinetics Pharmaceuticals's address is: Building No. 2, San Diego, CA, United States, 92121
What is Crinetics Pharmaceuticals's ISIN number?
Crinetics Pharmaceuticals's international securities identification number is: US22663K1079
What is Crinetics Pharmaceuticals's CUSIP number?
Crinetics Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 22663K107

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site